Impact of New Chemotherapeutic and Targeted Agents on Survival in Stage IV Non-Small Cell Lung Cancer

PURPOSE. Significant advances in the systemic management of metastatic non-small cell lung cancer (NSCLC) have occurred over the past decade, with options now including multiple lines of chemotherapy, epidermal growth factor receptor inhibitors, and antiangiogenic agents. Improvements in overall sur...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Yu, Joanne L., Simmons, Christine, Victor, J. Charles, Han, Dolly, Hogeveen, Sophie, Leighl, Natasha, Verma, Sunil
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: AlphaMed Press 2011
Aiheet:
Lung Cancer
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3228167/
https://ncbi.nlm.nih.gov/pubmed/21835896
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0079
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia